FDA
-
-
-
-
-
-
-
Neuronetics names new CFO, promotes executive, and loses legal chief
-
-
-
-
-
-
-
Neuronetics and ANT Neuro Announce Strategic Collaboration to Integrate Neuronavigation with NeuroStar TMS Treatment
-
-
-
-
-
-
-
Neuronetics Announces Chief Financial Officer Transition
-
-
-
-
-
-
-
Neuronetics reports preliminary Q4 revenue of $41.8 million
-
-
-
-
-
-
-
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
-
-
-
-
-
-
Neuronetics names Steven Pfanstiel as new chief financial officer
-
-
-
-
-
-
-
Neuronetics to Report First Quarter 2025 Financial and Operating Results and Host Conference Call
-
329,907 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

